13D Filing: Delphi Ventures VIII LP and Karyopharm Therapeutics Inc. (KPTI)

NUMBER
OF
SHARES
BENEFICIALLY
OWNED BY EACH
REPORTING
PERSON
WITH

5

SOLE
VOTING POWER
21,883 shares, except that DMP VIII, the general partner of DBI VIII, may be deemed to have sole power to vote these shares,
and Bochnowski, Douglass, Pakianathan and Roeder, the managing members of DMP VIII, may be deemed to have shared power to
vote these shares.

6

SHARED
VOTING POWER
See response to row 5.

7

SOLE
DISPOSITIVE POWER
21,883 shares, except that DMP VIII, the general partner of Delphi VIII, may be deemed to have sole power to dispose of these
shares, and Bochnowski, Douglass, Pakianathan and Roeder, the managing members of DMP VIII, may be deemed to have shared power
to dispose of these shares.

8

SHARED
DISPOSITIVE POWER
See response to row 7.

1	NAME OF REPORTING SS OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON Delphi BioInvestments VIII, L.P. (“DBI VIII”)
2	CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) ¨ (b) x
3	SEC USE ONLY
4	CITIZENSHIP OR PLACE OF ORGANIZATION Delaware

9	AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 21,883
10	CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES* ¨
11	PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9 0.0%
12	TYPE OF REPORTING PERSON* PN

13D Filing: Delphi Ventures VIII LP and Karyopharm Therapeutics Inc. (KPTI)

Published on June 9, 2017 at 12:41 pm by Insider Monkey Staff in Hedge Funds

Page 3 of 12 – SEC Filing

Follow Karyopharm Therapeutics Inc. (NASDAQ:KPTI)

Follow Karyopharm Therapeutics Inc. (NASDAQ:KPTI)

AI Fire Sale: Insider Monkey’s #1 AI Stock Pick Is On A Steep Discount

Published on May 1, 2024 at by Inan Dogan, PhD

A New Dawn is Coming to U.S. Stocks

Published on May 2, 2024 at by Insider Monkey Staff